Lupin Gets USFDA Approval for Generic Amifampridine Tablets
Lupin has won USFDA approval for generic amifampridine 10 mg tablets to treat Lambert-Eaton myasthenic syndrome, with 180-day shared generic exclusivity.
LUPIN-USFDA-APPROVAL
Lupin Secures USFDA Tentative Approval for Pitolisant Tablets, Expands CNS Portfolio
Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) […]
